the aid library

LIST OPTIONS

Filter

27747

Direction:

Наркотики? Алкоголь? Таблетки? У якийсь момент веселощі закінчаться!

Рафаель Гассманн, Кріста Мерферт-Діте et al. (2022) CC

Напиватися з друзями чи приймати наркотики спочатку весело. Усі говорять, що це безпечно, що ти тримаєш все під контролем і можеш зупинитися у будь-який момент! Але �... more

Наркотики? алкоголь? таблетки? Когда-то удовольствию приходит конец!

Dr. Christine Hutterer et al. (2022) CC

Сначала кажется классным – напиться с друзьями, принять наркотики. Все говорят, что это безопасно, что ты держишь все под контролем и в любой момент можешь останови... more

External Link

Pollution and the Heart

Rajagopalan, S.; Landrigan, P.J. The New England Journal of Medicine (2021) CC

Cardiovascular diseases are the world’s leading cause of disability and death. Such diseases were responsible in 2019 for an estimated 18.6 million deaths globally and 957,000 deaths in the United States.

Cardiovascular diseases (CVDs)

World Health Organization WHO (2021) C_WHO

Key facts - Cardiovascular diseases (CVDs) are the leading cause of death globally. - An estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. - Over three quarters of CVD deaths take place in low- an... more

What is Peripheral Artery Disease (PAD)?

American Heart Association (2021) CC

Peripheral artery disease is similar to coronary artery disease (CAD). Peripheral artery disease is a narrowing of the peripheral arteries that carry blood away from the heart to other parts of the body. The most common type is lower-extremity PAD, in which blood flow is reduced to the legs and fee... more

External Link

South African cardiovascular risk stratification guideline for non-cardiac surgery

Alphonsus, C.; Naidoo, N.; Motshabi, P. et al. South African Medical Journal (2021) CC

The South African (SA) guidelines for cardiac patients for non-cardiac surgery were developed to address the need for cardiac risk assessment and risk stratification for elective non-cardiac surgical patients in SA, and more broadly in Africa. The guidelines were developed by updating the Canadian ...Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Non-cardiac Surgery, with a search of literature from African countries and recent publications. The updated proposed guidelines were then evaluated in a Delphi consensus process by SA anaesthesia and vascular surgical experts. The recommendations in these guidelines are: 1. We suggest that elective non-cardiac surgical patients who are 45 years and older with either a history of coronary artery disease, congestive cardiac failure, stroke or transient ischaemic attack, or vascular surgical patients 18 years or older with peripheral vascular disease require further preoperative risk stratification as their predicted 30-day major adverse cardiac event (MACE) risk exceeds 5% (conditional recommendation: moderate-quality evidence). 2. We do not recommend routine non-invasive testing for cardiovascular risk stratification prior to elective non-cardiac surgery in adults (strong recommendation: low-to-moderate-quality evidence). 3. We recommend that elective non-cardiac surgical patients who are 45 years and older with a history of coronary artery disease, or stroke or transient ischaemic attack, or congestive cardiac failure or vascular surgical patients 18 years or older with peripheral vascular disease should have preoperative natriuretic peptide (NP) screening (strong recommendation: high-quality evidence). 4. We recommend daily postoperative troponin measurements for 48 - 72 hours for non-cardiac surgical patients who are 45 years and older with a history of coronary artery disease, or stroke or transient ischaemic attack, or congestive cardiac failure or vascular surgical patients 18 years or older with peripheral vascular disease, i.e. (i) a baseline risk >5% for MACE 30 days after elective surgery (if no preoperative NP screening), or (ii) an elevated B-type natriuretic peptide (BNP)/N-terminal-prohormone B-type natriuretic peptide (NT-proBNP) measurement before elective surgery (defined as BNP >99 pg/mL or a NT-proBNP >300 pg/mL) (conditional recommendation: moderate-quality evidence). Additional recommendations are given for the management of myocardial injury after non-cardiac surgery (MINS) and medications for comorbidities. more

Diabetes Mellitus: Insights from Epidemiology, Biochemistry, Risk Factors, Diagnosis, Complications and Comprehensive Management

Alam, S.; Hasan, K.; Neaz, S.; et al. Molecular Diversity Preservation International MDPI (2021) CC2

Diabetes mellitus has become a serious and chronic metabolic disorder that results from a complex interaction of genetic and environmental factors, principally characterized by hyperglycemia, polyuria, and polyphagia. Uncontrolled high blood sugar can result in a host of diabetic complications. Prol... more

Country snapshot of Diabetes Prevention and Control in the Americas 2021

Pan American Health Organization PAHO (2021) C_WHO

Diabetes is a major public health problem in the Americas and worldwide, demanding special attention and integrated response. It is estimated that more than 62 million adults are living with diabetes in the Americas. The projections show that diabetes prevalence will continue to increase to at least... more

Factsheet – 5 facts about alcohol and cancer

World Health Organization WHO (2021) CC

This factsheet provides five important facts for policy makers, health professionals and the general public about the links between alcohol consumption and a range of cancer types. This affects not only people who drink alcohol but also their families, friends and communities. - Alcohol causes at l... more